Home / About / Press Releases

Press Releases

11.04.2024Shockwave Medical Unveils First Clinical Outcomes of New IVL Platform in Late-Breaking Presentation at VIVA 2024
11.04.2024Shockwave Medical Further Validates Utility of Intravascular Lithotripsy in Lower Limb Lesions in Late-Breaking Presentation at VIVA 2024
10.28.2024Shockwave Medical Completes Enrollment in All-Female Coronary IVL Study
09.16.2024Shockwave Medical Expands U.S. Peripheral IVL Portfolio with Enhanced Catheter
05.31.2024Johnson & Johnson Completes Acquisition of Shockwave Medical
05.06.2024Shockwave Medical Reports First Quarter 2024 Financial Results
04.08.2024Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World’ Study
04.05.2024Johnson & Johnson to Acquire Shockwave Medical
03.26.2024Shockwave Medical to Participate in the 23rd Annual Needham Virtual Healthcare Conference
02.15.2024Shockwave Medical Reports Fourth Quarter and Full Year 2023 Financial Results
01.29.2024Shockwave Medical Appoints Renee Gaeta as Chief Financial Officer
01.08.2024Shockwave Medical Provides Quarterly Earnings Release Dates for 2024
12.20.2023Shockwave Medical to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
11.15.2023Shockwave Medical to Participate in the Piper Sandler 35th Annual Healthcare Conference
11.09.2023New Shockwave Coronary IVL Publication Shows Similar Outcomes in Women And Men
11.06.2023Shockwave Medical Reports Third Quarter 2023 Financial Results
11.03.2023Centers for Medicare & Medicaid Services Establishes New Category I CPT® Add-On Code for Coronary IVL
10.26.2023Shockwave Medical Announces Details for Conference Call Discussing Third Quarter 2023 Results and Participation in Upcoming Investor Conference
10.20.2023Shockwave Medical Introduces Enhanced Coronary IVL Catheter in the United States
10.19.2023New Shockwave Coronary IVL Publications Confirm Safety and Efficacy Across Multiple Calcium Morphologies
10.04.2023Shockwave Medical to Livestream 2023 Investor Innovation Day
09.12.2023Shockwave Medical Appoints Nick West as Associate Chief Medical Officer
09.11.2023Shockwave Medical Announces Dan Puckett to Retire as CFO in 2024
08.22.2023Shockwave Medical to Participate in Upcoming Investor Conferences
08.11.2023Shockwave Medical Prices Upsized Private Offering of $650.0 Million of 1.00% Convertible Senior Notes Due 2028
08.10.2023Shockwave Medical Announces Proposed Private Offering of $500.0 Million of Convertible Senior Notes
08.07.2023Shockwave Medical Reports Second Quarter 2023 Financial Results
08.02.2023Centers For Medicare & Medicaid Services Creates New Hospital Inpatient Payment for Coronary Intravascular Lithotripsy
07.18.2023Shockwave Medical Announces Details for Conference Call Discussing Second Quarter 2023 Results and Participation in Upcoming Investor Conference
05.31.2023Shockwave Medical Publishes 2022 ESG Report
05.17.2023Shockwave Appoints Kevin Ballinger to Board of Directors
05.15.2023Shockwave Medical Launches New Coronary IVL Catheter Internationally and Enrolls First Patient in All-Female Empower Study
05.08.2023Shockwave Medical Reports First Quarter 2023 Financial Results
04.24.2023Shockwave Medical Announces Details for Conference Call Discussing First Quarter 2023 Results and Participation in Upcoming Investor Conference
04.11.2023Shockwave Medical Completes Acquisition of Neovasc
03.14.2023Shockwave Medical Announces U.S. Launch of New Peripheral IVL Catheter
02.16.2023Shockwave Medical Reports Fourth Quarter and Full Year 2022 Financial Results
01.31.2023Updated SCAI Guidance Includes Coronary IVL as a Treatment Option in All U.S. Catheterization Labs Regardless of Surgical Backup Status
01.17.2023Shockwave Medical Announces Agreement to Acquire Neovasc
01.04.2023Shockwave Medical Provides Quarterly Earnings Release Dates for 2023
11.22.2022Shockwave Medical to Participate in the Piper Sandler 34th Annual Healthcare Conference
11.16.2022Shockwave Medical Publishes Inaugural ESG Report
11.07.2022Shockwave Medical Reports Third Quarter 2022 Financial Results
11.01.2022Shockwave Confirms Consistent Outcomes for IVL in the Largest Prospective “Real World” Study of Patients with Heavily Calcified Peripheral Arterial Disease
10.20.2022Shockwave Medical Announces Details for Conference Call Discussing Third Quarter 2022 Results
09.19.2022Shockwave Medical Initiates All-Female Coronary IVL Study
08.31.2022Correcting and Replacing: Shockwave Medical to Participate in Two Upcoming Investor Conferences
08.26.2022Shockwave Medical to Participate in Two Upcoming Investor Conferences
08.08.2022Shockwave Medical Reports Second Quarter 2022 Financial Results
07.25.2022Shockwave Medical Announces Details for Conference Call Discussing Second Quarter 2022 Results and Participation in Upcoming Investor Conference
05.23.2022Shockwave Medical and Genesis MedTech Obtain Regulatory Approval in China for Intravascular Lithotripsy
05.19.2022Shockwave IVL Maintains Superiority to Angioplasty in Calcified Peripheral Disease at Two Years
05.19.2022Shockwave IVL Coronary Studies Demonstrate Excellent PCI Outcomes in Both Women and Men at One Year
05.09.2022Shockwave Medical Reports First Quarter 2022 Financial Results
04.27.2022Shockwave Medical Announces Details for Conference Call Discussing First Quarter 2022 Results and Participation in Upcoming Investor Conferences
03.31.2022Shockwave Medical Announces Global Launch of New Peripheral Intravascular Lithotripsy Catheter
03.30.2022Shockwave Medical Announces Japanese Regulatory Approval of Coronary IVL
03.08.2022Shockwave Medical Named to Fast Company’s “Most Innovative Company” List
02.17.2022Shockwave Medical Reports Fourth Quarter and Full Year 2021 Financial Results
02.04.2022Shockwave Medical to Participate in the SVB Leerink 11th Annual Global Healthcare Conference
01.04.2022Shockwave Medical Provides Quarterly Earnings Release Dates for 2022
11.22.2021Shockwave Medical Enrolls First Patient in Disrupt BTK II Study for Long, Calcified, Below the Knee Lesions
11.17.2021Shockwave Medical to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
11.08.2021Shockwave Medical Reports Third Quarter 2021 Financial Results
11.05.2021Shockwave Medical Unveils First One-Year Results of Coronary Intravascular Lithotripsy
11.03.2021Centers For Medicare & Medicaid Services Increases Hospital Outpatient Payment for Peripheral Intravascular Lithotripsy
10.06.2021Shockwave IVL Consistently Treats “Real World” Calcium Across Multiple Peripheral Vessel Beds
10.05.2021Shockwave Medical to Report Third Quarter 2021 Financial Results on November 8, 2021
08.26.2021Shockwave Medical to Participate in Two Upcoming Virtual Investor Conferences
08.09.2021Shockwave Medical Reports Second Quarter 2021 Financial Results
07.28.2021Shockwave Medical to Present at the Canaccord Genuity 41st Annual Growth Conference
07.15.2021Shockwave Medical to Report Second Quarter 2021 Financial Results on August 9, 2021
06.28.2021Publications Validate Clinical Safety and Efficacy of Shockwave Intravascular Lithotripsy
06.11.2021CMS Grants Transitional Pass-Through (TPT) Payment for Shockwave’s Coronary IVL
05.10.2021Shockwave Medical Reports First Quarter 2021 Financial Results
04.27.2021CMS Proposes Additional Payment for Shockwave’s Coronary IVL in Hospital Inpatient Cases
04.27.2021Shockwave Medical to Participate in the Bank of America Securities 2021 Health Care Conference
04.12.2021Shockwave Medical to Report First Quarter 2021 Financial Results on May 10, 2021
03.30.2021Shockwave Provides Update on U.S. Launch of Coronary IVL System
03.25.2021Shockwave Appoints Sara Toyloy to Board of Directors
03.22.2021Shockwave Announces Joint Venture in China
02.17.2021Shockwave Medical Reports Fourth Quarter and Full Year 2020 Financial Results
02.16.2021Shockwave Intravascular Lithotripsy FDA Approved to Treat Advanced Heart Disease
01.19.2021Shockwave Medical to Report Fourth Quarter and Full Year 2020 Financial Results on February 17, 2021
12.04.2020Centers for Medicare & Medicaid Services Creates New Codes That Establish Specific Payment for Intravascular Lithotripsy Performed Below the Knee
11.18.2020Shockwave Medical to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
11.09.2020Shockwave Medical Reports Third Quarter 2020 Financial Results
11.07.2020Shockwave IVL Is Superior to Angioplasty in Severely Calcified Peripheral Artery Disease
10.22.2020Shockwave Medical Announces VIVA20 Investor Update and Conference Call Discussing Third Quarter 2020 Results
10.20.2020Shockwave Disrupt PAD III Results to be Presented in Late-Breaking Session at VIVA20
10.15.2020Shockwave IVL Meets Safety and Effectiveness Endpoints in U.S. Coronary Pivotal IDE Study
10.01.2020Shockwave Announces Updated Time for CAD III Investor Webcast Event in Conjunction with TCT Connect
09.15.2020Shockwave Coronary IVL U.S. Pivotal Study Results to be Presented in Late-Breaking Session at TCT Connect
08.26.2020Shockwave Medical to Participate in Upcoming September Investor Conferences
08.11.2020Shockwave Medical Reports Second Quarter 2020 Financial Results
07.30.2020Shockwave Medical to Present at the Canaccord Genuity 40th Annual Growth Conference
07.21.2020Shockwave Medical to Report Second Quarter 2020 Financial Results on August 11, 2020
07.20.2020Shockwave Appoints Maria Sainz to Board of Directors
07.08.2020Shockwave Announces Decisions From the U.S. Patent and Trademark Office on Inter Partes Review Proceeding
06.17.2020Shockwave Announces Pricing of Public Offering of Common Stock
06.16.2020Shockwave Announces Proposed Public Offering of Common Stock
06.08.2020Shockwave Medical Announces That CMS Has Created New Codes for Intravascular Lithotripsy
05.12.2020Shockwave Medical Reports First Quarter 2020 Financial Results
04.30.2020Shockwave Medical to Present at the Bank of America Securities 2020 Health Care Conference
04.21.2020Shockwave Medical to Report First Quarter 2020 Financial Results on May 12, 2020
04.13.2020Shockwave Completes Enrollment of Coronary Intravascular Lithotripsy Study in Japan
04.06.2020Shockwave Completes Enrollment in Pivotal Study for Coronary Intravascular Lithotripsy
02.13.2020Shockwave Medical Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Full Year 2020 Financial Outlook
01.21.2020Shockwave Medical to Report Fourth Quarter and Full Year 2019 Financial Results on February 13, 2020
11.15.2019Shockwave Announces Pricing of Public Offering of Common Stock
11.12.2019Shockwave Announces Proposed Public Offering of Common Stock
11.08.2019Shockwave Medical to Participate in the 13th Annual Canaccord Genuity Medical Technologies & Diagnostics Forum
11.07.2019Shockwave Medical Reports Third Quarter 2019 Financial Results
11.07.2019Shockwave Initiates Study of Coronary Intravascular Lithotripsy in Japan
11.04.2019Shockwave Announces Commercial Availability of Below-the-Knee IVL Catheter
10.17.2019Shockwave Medical to Report Third Quarter 2019 Financial Results on November 7, 2019
09.25.2019Shockwave Study Demonstrates Strong Safety and Procedural Success of Coronary IVL in Europe
09.03.2019Shockwave Receives FDA Breakthrough Device Designation for the Coronary IVL System
08.21.2019Shockwave Medical to Participate in Upcoming Investor Conferences
08.05.2019Shockwave Medical Reports Second Quarter 2019 Financial Results
07.23.2019Shockwave Medical to Participate in the 39th Annual Canaccord Genuity Global Growth Conference
07.23.2019Shockwave Medical to Report Second Quarter 2019 Financial Results on August 5, 2019
06.10.2019Shockwave Appoints Hajime Tada as General Counsel
05.15.2019Shockwave Appoints Keith D. Dawkins M.D. as Chief Medical Officer
05.08.2019Shockwave Medical Reports First Quarter 2019 Financial Results
05.01.2019Shockwave Medical to Present at the Bank of America Merrill Lynch 2019 Health Care Conference
04.24.2019Shockwave Medical to Report First Quarter 2019 Financial Results on May 8, 2019
04.03.2019Shockwave Completes Enrollment of Disrupt CAD II Study
03.11.2019ShockWave Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
03.07.2019ShockWave Announces Pricing of Initial Public Offering
02.07.2019Shockwave Appoints Laura Francis to Board of Directors
01.14.2019Shockwave Initiates U.S. Pivotal Study for Coronary Intravascular Lithotripsy
01.04.2019Shockwave Announces Appointment of Ray Larkin as Chairman of the Board
12.11.2018Shockwave Announces Collaboration with Abiomed on Physician Training
05.21.2018Shockwave Launches Coronary Intravascular Lithotripsy in Europe
10.10.2017Shockwave Medical Announces $35 Million in New Financing
09.19.2017Shockwave Medical Announces U.S. Commercial Availability of Lithoplasty® System and Enrollment of First Patient in DISRUPT PAD III Global Clinical Trial
06.21.2017Shockwave Medical Announces U.S. Commercial Availability of Lithoplasty® System and Enrollment of First Patient in DISRUPT PAD III Global Clinical Trial
05.05.2017Shockwave Medical Announces CE Mark for Coronary Lithoplasty® System and Activities at EuroPCR 2017

Media Relations Contact

Scott Shadiow
Phone: +1.408-385-7563
media@shockwavemedical.com

Ready to Make Waves with Shockwave Medical?

Looking for careers? Click here.